INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Company

Cartesian Therapeutics, Inc.

Filed

November 15, 2023

Period of Report

November 13, 2023

Accession Number

0001062993-23-020916